Surgery Partners, Inc.
SGRY
$12.36
-$0.29-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.92% | -808.00% | 93.37% | 65.25% | -242.27% |
| Total Depreciation and Amortization | 51.65% | -1.99% | 11.02% | 7.08% | -32.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.74% | 41.53% | -6.38% | -70.44% | 190.39% |
| Change in Net Operating Assets | 0.00% | -10.18% | 70.65% | -80.63% | -11.70% |
| Cash from Operations | 23.68% | 2.83% | 1,255.00% | -94.61% | 70.86% |
| Capital Expenditure | 35.35% | 15.38% | -3.08% | -1.79% | -10.40% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 693.75% | 336.36% | -- |
| Cash Acquisitions | -2,280.43% | -15.00% | 90.91% | 49.77% | -229.32% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.06% | -153.49% | 40.69% | -400.00% | -3.57% |
| Cash from Investing | -172.94% | -2,300.00% | 102.75% | 31.60% | -125.20% |
| Total Debt Issued | 441.44% | -24.14% | -21.07% | -19.67% | 57.90% |
| Total Debt Repaid | -259.88% | 10.61% | -50.96% | 30.03% | -26.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.69% | 0.20% | 20.28% | -35.23% | -16.46% |
| Cash from Financing | 170.39% | -34.35% | -307.28% | -37.08% | 757.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.16% | -324.52% | 151.74% | -184.28% | 474.70% |